生鲜乳价格近期呈现企稳迹象，旺季备货期有望开启。乳业股涨幅居前，优然牧业(09858)涨11.64%，报1.63港元；现代牧业(01117)涨5.95%；中国飞鹤(06186)涨2.22%；蒙牛乳业(02319)涨1.74%。The price of fresh milk has recently shown signs of stabilization, and the peak season stocking period is expected to begin.
According to Zhitong Finance APP, the Hong Kong stock market's Hang Seng Index did not hit the limit up during the early trading session, standing at 20,310 points; the Hang Seng TECH Index fell by 0.23%.
Spot gold has broken through the $2,700 mark, with the market focusing on tonight's inflation data from the USA. Golden Industrial Concept stocks rose collectively, with ZHAOJIN MINING (01818) up 5.47%; LINGBAO GOLD (03330) up 6.18%; CHINAGOLDINTL (02099) up 4.6%; SD GOLD (01787) up 2.41%.
The price of fresh milk has recently shown signs of stabilization, and the peak season stocking period is expected to begin. Dairy industry stocks had significant gains, with CH MODERN D (09858) up 11.64%, reported at 1.63 HKD; CH MODERN D (01117) up 5.95%; CHINA FEIHE (06186) up 2.22%; and MENGNIU DAIRY (02319) up 1.74%.
FOSUN TOURISM (01992) announced its privatization, and the company's stock price soared over 80%.
MEDBOT-B (02172) rose over 10%, with vascular interventional consumables initializing, and neuro-interventional bulk purchasing also accelerating.
MAIFUSHI (02556) rose over 5% to a new high, having reached strategic partnerships with multiple companies, and Institutions are bullish on the growth potential of the company's performance empowered by AI.
FOURTH PARADIGM (06682) surged over 7%, the performance of the prophet AI platform Business is impressive, and the company is expected to continuously increase its market share in the future.
YADEA (01585) rose over 6%, with total global sales exceeding 0.1 billion units, and the new national standards are expected to accelerate industry market share concentration.
MEDBOT-B (02252) increased by over 24% again, the company completed the placement of a total of 34.7 million shares, raising over 0.266 billion Hong Kong dollars.
Kejie Pharmaceutical-B (02171) surged over 16%, as the company showcased the research results of Saikeze, CT071, and CT0590 at the ASH annual meeting.
